To make an appointment with a Valley cancer specialist,
please call 201-634-5339.

Lymphoma / Leukemia

Font ++ Click to Print

 

CLL Inform

“informCLL™: A Disease Registry for Patients with Chronic Lymphocytic Leukemia”

Study Objective: To describe current treatment patterns in the real-world setting among CLL patients who are initiating treatment with novel therapies including approved oral kinase inhibitors or other approved anti-CLL therapies/regimens.

Inclusion Criteria:

  • Age of at least 18 years
  • Clinical diagnosis of CLL/SLL
  • Initiating treatment within 30 days of enrollment with novel therapies
  • Availability of documentation of previous CLL/SLL treatment and duration
  • Willing and able to provide informed consent
  • Willing and able to complete PRO instrument
  • Willing and able to provide information on patient survey questionnaire
  • Willing and able to provide a blood sample at time of enrollment


Exclusion Criteria:

  • Diagnosis of B-cell malignancies other than CLL/SLL
  • Estimated life expectancy <6 months
  • Currently enrolled in any interventional clinical trial with a non-approved, investigational agent for CLL/SLL at study entry


Principal Investigator: Barry Fernbach, M.D.

Click here for more information on CLL Inform


 

 


Find a Doctor
 
View all physicians
Contact the Blumenthal Cancer Center

Have a question? Call 201-634-5339 or complete the form below. If you are experiencing a medical emergency, please call your doctor or emergency services provider.

(-
Retype the numbers below:
 Security code
----